Compound 1908
Identifiers
- Canonical SMILES:
Cc1ncc2CN=C(c3ccccc3F)c3cc(Cl)ccc3-n12
- IUPAC name:
12-chloro-9-(2-fluorophenyl)-3-methyl-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
- InChi:
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
- InChiKey:
DDLIGBOFAVUZHB-UHFFFAOYSA-N
External links
4192 |
CHEMBL655 |
08J |
DB00683 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 325.08 g/mol | |||
HBA | 3 | |||
HBD | 0 | |||
HBA + HBD | 3 | |||
AlogP | 3.97 | |||
TPSA | 30.18 | |||
RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
1.0000 | Midazolam | DB00683 | |
0.6056 | Alprazolam | DB00404 | |
0.5955 | Estazolam | DB01215 | |
0.5873 | Adinazolam | DB00546 | |
0.5798 | Triazolam | DB00897 | |
0.5221 | Remimazolam | DB12404 | |
0.4976 | Clonazolam | DB14716 | |
0.4780 | Pyrazolam | DB14718 | |
0.4778 | Nitrazolam | DB14717 | |
0.4623 | Nizofenone | DB13546 | |
0.4274 | MLN8054 | DB13061 | |
0.4271 | Fludiazepam | DB01567 | |
0.4059 | Flurazepam | DB00690 | |
0.4009 | Ethyl loflazepate | DB01545 | |
0.3953 | Etizolam | DB09166 |